Multi-platform ’Omics Analysis of Human Ebola Virus Disease Pathogenesis

Cell Host and Microbe

Volumn 22, Issue 6, 2017, Pages 817-829.e8

  Eisfeld, Amie J ^a   Halfmann, Peter J ^a   Wendler, Jason P ^b   Kyle, Jennifer E ^b   Burnum Johnson, Kristin E ^b   Peralta, Zuleyma ^c   Maemura, Tadashi ^a,d   Walters, Kevin B ^a,h   Watanabe, Tokiko ^d   Fukuyama, Satoshi ^d   Yamashita, Makoto ^d   Jacobs, Jon M ^b   Kim, Young Mo ^b   Casey, Cameron P ^a,b   Stratton, Kelly G ^b   Webb Robertson, Bobbie Jo M ^b   Gritsenko, Marina A ^b   Monroe, Matthew E ^b   Weitz, Karl K ^b   Shukla, Anil K ^b   Tian, Mingyuan ^e   Neumann, Gabriele ^a   Reed, Jennifer L ^e   van Bakel, Harm ^c   Metz, Thomas O ^b   Smith, Richard D ^b   Waters, Katrina M ^b   N'jai, Alhaji ^a,f   Sahr, Foday ^g   Kawaoka, Yoshihiro ^a,d   more..

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e University of Wisconsin Madison   (United States)

^f UNIVERSITY OF SIERRA LEONE   (Sierra Leone)

^g 34th Regimental Military Hospital at Wilberforce   (Sierra Leone)

^h Southern Research Institute   (United States)

Author keywords

biomarker; Ebola virus; human; inflammation; neutrophils; omics; pancreatitis; pathogenesis; sepsis; systems biology

Indexed keywords

BIOLOGICAL MARKER; HOST FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; LIPIDOME; PANCREAS ENZYME; TRANSCRIPTOME; TUMOR NECROSIS FACTOR; PLASMA PROTEIN; PROTEOME;

ADULT; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FATALITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; IMMUNE RESPONSE; MACROPHAGE; MALE; METABOLOME; METABOLOMICS; NECROPTOSIS; NEUTROPHIL; NONHUMAN; OMICS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEOMICS; SEPSIS; SURVIVOR; T LYMPHOCYTE; TISSUE INJURY; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE; CHEMISTRY; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; MONONUCLEAR CELL; PATHOLOGY; PLASMA;

BLOOD PROTEINS; GENE EXPRESSION PROFILING; HEMORRHAGIC FEVER, EBOLA; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; PLASMA; PROTEOME;

EID: 85034453474     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.10.011     Document Type: Article

References (41)

1. Agarwal, N., Pitchumoni, C.S., Acute pancreatitis: a multisystem disease. Gastroenterologist 1 (1993), 115–128.
2. Blow, J.A., Dohm, D.J., Negley, D.L., Mores, C.N., Virus inactivation by nucleic acid extraction reagents. J. Virol. Methods 119 (2004), 195–198.
3. Carmona-Rivera, C., Kaplan, M.J., Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin. Immunopathol. 35 (2013), 455–463.
4. Darcy, C.J., Minigo, G., Piera, K.A., Davis, J.S., McNeil, Y.R., Chen, Y., Volkheimer, A.D., Weinberg, J.B., Anstey, N.M., Woodberry, T., Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit. Care, 18, 2014, R163.
5. Etzerodt, A., Moestrup, S.K., CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid. Redox Signal. 18 (2013), 2352–2363.
6. Filippas-Ntekouan, S., Liberopoulos, E., Elisaf, M., Lipid testing in infectious diseases: possible role in diagnosis and prognosis. Infection, 2017, 10.1007/s15010-017-1022-3.
7. Halfmann, P., Kim, J.H., Ebihara, H., Noda, T., Neumann, G., Feldmann, H., Kawaoka, Y., Generation of biologically contained Ebola viruses. Proc. Natl. Acad. Sci. USA 105 (2008), 1129–1133.
8. Hellman, J., Addressing the complications of ebola and other viral hemorrhagic fever infections: using insights from bacterial and fungal sepsis. PLoS Pathog., 11, 2015, e1005088.
9. Hunt, L., Gupta-Wright, A., Simms, V., Tamba, F., Knott, V., Tamba, K., Heisenberg-Mansaray, S., Tamba, E., Sheriff, A., Conteh, S., et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 15 (2015), 1292–1299.
10. Kaplan, M.J., Radic, M., Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189 (2012), 2689–2695.
11. Kash, J.C., Walters, K.A., Kindrachuk, J., Baxter, D., Scherler, K., Janosko, K.B., Adams, R.D., Herbert, A.S., James, R.M., Stonier, S.W., et al. Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Sci. Transl. Med., 9, 2017.
12. Kelly, R.T., Page, J.S., Luo, Q., Moore, R.J., Orton, D.J., Tang, K., Smith, R.D., Chemically etched open tubular and monolithic emitters for nanoelectrospray ionization mass spectrometry. Anal. Chem. 78 (2006), 7796–7801.
13. Lacroix, R., Dignat-George, F., Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb. Res. 129:Suppl 2 (2012), S27–S29.
14. Leligdowicz, A., Fischer, W.A. 2nd, Uyeki, T.M., Fletcher, T.E., Adhikari, N.K., Portella, G., Lamontagne, F., Clement, C., Jacob, S.T., Rubinson, L., et al. Ebola virus disease and critical illness. Crit. Care, 20, 2016, 217.
15. Llewelyn, M.J., Berger, M., Gregory, M., Ramaiah, R., Taylor, A.L., Curdt, I., Lajaunias, F., Graf, R., Blincko, S.J., Drage, S., et al. Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit. Care, 17, 2013, R60.
16. Ludtke, A., Ruibal, P., Becker-Ziaja, B., Rottstegge, M., Wozniak, D.M., Cabeza-Cabrerizo, M., Thorenz, A., Weller, R., Kerber, R., Idoyaga, J., et al. Ebola virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes. J. Infect Dis. 214:suppl 3 (2016), S275–S280.
17. Maiolica, A., Borsotti, D., Rappsilber, J., Self-made frits for nanoscale columns in proteomics. Proteomics 5 (2005), 3847–3850.
18. Malfertheiner, P., Kemmer, T.P., Clinical picture and diagnosis of acute pancreatitis. Hepatogastroenterology 38 (1991), 97–100.
19. Martinez, F.O., Gordon, S., Locati, M., Mantovani, A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177 (2006), 7303–7311.
20. Messaoudi, I., Amarasinghe, G.K., Basler, C.F., Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 13 (2015), 663–676.
21. Nanclares, C., Kapetshi, J., Lionetto, F., de la Rosa, O., Tamfun, J.J., Alia, M., Kobinger, G., Bernasconi, A., Ebola virus disease, democratic republic of the Congo, 2014. Emerg. Infect Dis. 22 (2016), 1579–1586.
22. Palmer, C., Diehn, M., Alizadeh, A.A., Brown, P.O., Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics, 7, 2006, 115.
23. Park, D.W., Kwak, D.S., Park, Y.Y., Chang, Y., Huh, J.W., Lim, C.M., Koh, Y., Song, D.K., Hong, S.B., Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. J. Crit. Care, 29, 2014, 882.e5-11.
24. Raftery, M.J., Lalwani, P., Krautkrmer, E., Peters, T., Scharffetter-Kochanek, K., Kruger, R., Hofmann, J., Seeger, K., Kruger, D.H., Schonrich, G., beta2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J. Exp. Med. 211 (2014), 1485–1497.
25. Ruibal, P., Oestereich, L., Ludtke, A., Becker-Ziaja, B., Wozniak, D.M., Kerber, R., Korva, M., Cabeza-Cabrerizo, M., Bore, J.A., Koundouno, F.R., et al. Unique human immune signature of Ebola virus disease in Guinea. Nature 533 (2016), 100–104.
26. Sandquist, M., Wong, H.R., Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev. Clin. Immunol. 10 (2014), 1349–1356.
27. Schieffelin, J.S., Shaffer, J.G., Goba, A., Gbakie, M., Gire, S.K., Colubri, A., Sealfon, R.S., Kanneh, L., Moigboi, A., Momoh, M., et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N. Engl. J. Med. 371 (2014), 2092–2100.
28. Severino, P., Silva, E., Baggio-Zappia, G.L., Brunialti, M.K., Nucci, L.A., Rigato, O. Jr., da Silva, I.D., Machado, F.R., Salomao, R., Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia. PLoS One, 9, 2014, e91886.
29. Silke, J., Rickard, J.A., Gerlic, M., The diverse role of RIP kinases in necroptosis and inflammation. Nat. Immunol. 16 (2015), 689–697.
30. Smith, C.K., Kaplan, M.J., The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr. Opin. Rheumatol. 27 (2015), 448–453.
31. Soeters, P.B., Grecu, I., Have we enough glutamine and how does it work? A clinician's view. Ann. Nutr. Metab. 60 (2012), 17–26.
32. Song, W.M., Zhang, B., Multiscale embedded gene co-expression network analysis. PLoS Comput. Biol., 11, 2015, e1004574.
33. Velasquez, G.E., Aibana, O., Ling, E.J., Diakite, I., Mooring, E.Q., Murray, M.B., Time from infection to disease and infectiousness for Ebola virus disease, a systematic review. Clin. Infect. Dis. 61 (2015), 1135–1140.
34. Vives-Pi, M., Takasawa, S., Pujol-Autonell, I., Planas, R., Cabre, E., Ojanguren, I., Montraveta, M., Santos, A.L., Ruiz-Ortiz, E., Biomarkers for diagnosis and monitoring of celiac disease. J. Clin. Gastroenterol. 47 (2013), 308–313.
35. Vogt, L., Schmitz, N., Kurrer, M.O., Bauer, M., Hinton, H.I., Behnke, S., Gatto, D., Sebbel, P., Beerli, R.R., Sonderegger, I., et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 116 (2006), 2817–2826.
36. Wang, Y., Wu, J., Newton, R., Bahaie, N.S., Long, C., Walcheck, B., ADAM17 cleaves CD16b (FcgammaRIIIb) in human neutrophils. Biochim. Biophys. Acta 1833 (2013), 680–685.
37. Ward, P.A., Bosmann, M., A historical perspective on sepsis. Am. J. Pathol. 181 (2012), 2–7.
38. Wauquier, N., Becquart, P., Padilla, C., Baize, S., Leroy, E.M., Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl. Trop. Dis, 4, 2010.
39. Webster, N.L., Kedzierska, K., Azzam, R., Paukovics, G., Wilson, J., Crowe, S.M., Jaworowski, A., Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection. J. Leukoc. Biol. 79 (2006), 294–302.
40. WHO, Ebola Situation Report: 30 March 2016. 2016, World Health Organization http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016.
41. Zimmer, J.S., Monroe, M.E., Qian, W.J., Smith, R.D., Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom. Rev. 25 (2006), 450–482.